750 related articles for article (PubMed ID: 27265266)
1. MicroRNA-mediated maturation of human pluripotent stem cell-derived cardiomyocytes: Towards a better model for cardiotoxicity?
White MC; Pang L; Yang X
Food Chem Toxicol; 2016 Dec; 98(Pt A):17-24. PubMed ID: 27265266
[TBL] [Abstract][Full Text] [Related]
2. Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes.
Zhu R; Blazeski A; Poon E; Costa KD; Tung L; Boheler KR
Stem Cell Res Ther; 2014 Oct; 5(5):117. PubMed ID: 25688759
[TBL] [Abstract][Full Text] [Related]
3. Neonatal Transplantation Confers Maturation of PSC-Derived Cardiomyocytes Conducive to Modeling Cardiomyopathy.
Cho GS; Lee DI; Tampakakis E; Murphy S; Andersen P; Uosaki H; Chelko S; Chakir K; Hong I; Seo K; Chen HV; Chen X; Basso C; Houser SR; Tomaselli GF; O'Rourke B; Judge DP; Kass DA; Kwon C
Cell Rep; 2017 Jan; 18(2):571-582. PubMed ID: 28076798
[TBL] [Abstract][Full Text] [Related]
4. Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.
Yang X; Papoian T
J Appl Toxicol; 2018 Sep; 38(9):1166-1176. PubMed ID: 29484688
[TBL] [Abstract][Full Text] [Related]
5. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
[TBL] [Abstract][Full Text] [Related]
6. Qualitative transcriptional signatures for evaluating the maturity degree of pluripotent stem cell-derived cardiomyocytes.
Chen R; He J; Wang Y; Guo Y; Zhang J; Peng L; Wang D; Lin Q; Zhang J; Guo Z; Li L
Stem Cell Res Ther; 2019 Mar; 10(1):113. PubMed ID: 30925936
[TBL] [Abstract][Full Text] [Related]
7. Cardiomyocytes derived from pluripotent stem cells: progress and prospects from China.
Yang HT; Zhang M; Huang J; Liang H; Zhang P; Boheler KR
Exp Cell Res; 2013 Jan; 319(2):120-5. PubMed ID: 23022397
[TBL] [Abstract][Full Text] [Related]
8. Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes: a Critical Step for Drug Development and Cell Therapy.
Tan SH; Ye L
J Cardiovasc Transl Res; 2018 Oct; 11(5):375-392. PubMed ID: 29557052
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes.
Zhou J; Cui B; Wang X; Wang H; Zheng J; Guo F; Sun Y; Fan H; Shen J; Su J; Wang J; Zhao H; Tang Y; Gong T; Sun N; Liang P
Stem Cell Res Ther; 2023 Apr; 14(1):92. PubMed ID: 37061738
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytes.
Chun YW; Balikov DA; Feaster TK; Williams CH; Sheng CC; Lee JB; Boire TC; Neely MD; Bellan LM; Ess KC; Bowman AB; Sung HJ; Hong CC
Biomaterials; 2015 Oct; 67():52-64. PubMed ID: 26204225
[TBL] [Abstract][Full Text] [Related]
11. Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells:
Jiang Y; Park P; Hong SM; Ban K
Mol Cells; 2018 Jul; 41(7):613-621. PubMed ID: 29890820
[TBL] [Abstract][Full Text] [Related]
12. Functional improvement and maturation of human cardiomyocytes derived from human pluripotent stem cells by barbaloin preconditioning.
Yang H; Zhong W; Hamidi MR; Zhou G; Liu C
Acta Biochim Biophys Sin (Shanghai); 2019 Sep; 51(10):1041-1048. PubMed ID: 31518384
[TBL] [Abstract][Full Text] [Related]
13. Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.
Tzatzalos E; Abilez OJ; Shukla P; Wu JC
Adv Drug Deliv Rev; 2016 Jan; 96():234-244. PubMed ID: 26428619
[TBL] [Abstract][Full Text] [Related]
14. Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells.
Nemade H; Chaudhari U; Acharya A; Hescheler J; Hengstler JG; Papadopoulos S; Sachinidis A
Arch Toxicol; 2018 Apr; 92(4):1507-1524. PubMed ID: 29397400
[TBL] [Abstract][Full Text] [Related]
15. Concise Review: Criteria for Chamber-Specific Categorization of Human Cardiac Myocytes Derived from Pluripotent Stem Cells.
Kane C; Terracciano CMN
Stem Cells; 2017 Aug; 35(8):1881-1897. PubMed ID: 28577296
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes.
Chaudhari U; Nemade H; Gaspar JA; Hescheler J; Hengstler JG; Sachinidis A
Arch Toxicol; 2016 Dec; 90(12):3087-3098. PubMed ID: 26842497
[TBL] [Abstract][Full Text] [Related]
17. Developmental cues for the maturation of metabolic, electrophysiological and calcium handling properties of human pluripotent stem cell-derived cardiomyocytes.
Keung W; Boheler KR; Li RA
Stem Cell Res Ther; 2014 Jan; 5(1):17. PubMed ID: 24467782
[TBL] [Abstract][Full Text] [Related]
18. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
Talkhabi M; Aghdami N; Baharvand H
Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
[TBL] [Abstract][Full Text] [Related]
19. Maturation of human pluripotent stem cell derived cardiomyocytes in vitro and in vivo.
Gomez-Garcia MJ; Quesnel E; Al-Attar R; Laskary AR; Laflamme MA
Semin Cell Dev Biol; 2021 Oct; 118():163-171. PubMed ID: 34053865
[TBL] [Abstract][Full Text] [Related]
20. Fatty Acid-Treated Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes Exhibit Adult Cardiomyocyte-Like Energy Metabolism Phenotypes.
Horikoshi Y; Yan Y; Terashvili M; Wells C; Horikoshi H; Fujita S; Bosnjak ZJ; Bai X
Cells; 2019 Sep; 8(9):. PubMed ID: 31533262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
